MARY TEMPLIN: Open Payments
NPI 1760798961 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,202 in 151 payments from 23 companies in 2025. Trend: 2023 $4,304 · 2024 $5,079 · 2025 $3,202
Food & beverage: $3,202
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $624 |
| ABBVIE INC. | 20 | $322 |
| Galderma Laboratories, L.P. | 17 | $233 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $224 |
| MAYNE PHARMA COMMERCIAL LLC | 14 | $222 |
| Arcutis Biotherapeutics, Inc. | 12 | $220 |
| Lilly USA, LLC | 5 | $207 |
| Organon LLC | 5 | $198 |
| UCB, Inc. | 10 | $168 |
| LEO Pharma Inc. | 9 | $161 |
Products named: COSENTYX, Zoryve, NEMLUVIO, EBGLYSS, SKYRIZI, VTAMA, Bimzelx, ADBRY.
Industry payments across AL — which companies pay providers there.
